Oct 18
-
20
/
2025
Request a meeting by filling the form
Discover how Segmed is shaping the future of ophthalmology innovation with Real-World Imaging Data (RWiD) and Multimodal Datasets
Connect with us at AAO to explore how access to diverse, de-identified imaging datasets can accelerate AI research, enhance clinical insights, and support the development of cutting-edge ophthalmologic technologies.
At Segmed, we’re committed to advancing patient outcomes by making high-quality, real-world imaging data easily accessible for research and innovation. Our multimodal datasets — including radiology images, reports, and longitudinal data — are tailored for the needs of the AAO community. Backed by 100M+ imaging studies and experience supporting 35+ FDA-cleared products, Segmed ensures your developments meet the highest standards of rigor and reproducibility.
Meet us at AAO to learn how RWiD is driving advancements in:
Today’s AAO researchers and innovators are leveraging RWiD to train robust AI models, validate tools in multi-institutional datasets, and translate algorithmic innovation into clinical impact — all using diverse, de-identified imaging data from real patients in real settings.
.png)
Aline Lutz, MD PhD, is our Vice President of Clinical Insights and Real World Evidence. She is a physician-scientist specializing in healthcare technology, population health, and medical imaging research. At Segmed, she leads real-world imaging data (RWiD) initiatives, providing high-quality data for clinical trials and creating a meaningful impact on the healthcare ecosystem.
Request a meeting with Aline to explore how Segmed can support your AI ophthalmology innovations with RWiD.
